← All medicines
Femoston-conti 0.5 mg/2.5 mg film-coated tablets
Licence PA22668/014/003 · Marketed
- Licence holder
- Theramex Ireland Limited (all products →)
- Active substances
- Estradiol, Dydrogesterone
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC codes
- G03FA, G03FA14
- First authorised
- 01/10/2010
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.